New £1.2m project to explore sheep scab treatment resistance

Sheep scab has profound financial and welfare implications in areas where it is endemic worldwide (Photo: NADIS)
Sheep scab has profound financial and welfare implications in areas where it is endemic worldwide (Photo: NADIS)

Researchers in the UK have been awarded a £1.2 million grant to spearhead a project looking at resistance to sheep scab treatments.

Scientists will explore the mechanism of resistance to the macrocyclic lactone (ML) injectables in the sheep scab mite Psoroptes ovis, and how this resistance has spread across the UK.

Sheep scab remains a significant threat to livestock health and welfare, imposing substantial economic burdens on farmers across the UK.

The three-year grant will see Moredun Research Institute collaborate with the University of Glasgow, Scotland’s Rural College (SRUC) and the Sustainable Control of Parasites in Sheep (SCOPS) industry group.

Project lead Dr Stew Burgess, of Moredun, said the grant was a 'pivotal investment' in the mission to combat the growing challenge of ML resistance in the sheep scab mite.

He said: “With this funding, we aim to decode the genetic basis of resistance and its spread, providing the agricultural community with vital tools and updated strategies to manage this pervasive issue effectively.

“This project strengthens our collaborative efforts with partners at the University of Glasgow and SRUC and reinforces Moredun’s commitment to pioneering research that drives real-world impact.”

Sheep scab, which costs the industry between £80-200m annually, current relies on control strategies such as organophosphate (OP) sheep dips and ML injectables.

However, overreliance on ML injectables for controlling gastrointestinal nematodes (GIN) and sheep scab has led to the emergence of ML-resistant parasites, which has posed a significant threat to UK sheep welfare, researchers say.

While OP dipping is an effective alternative, it is associated with more complex safety requirements for both operators and the environment and, if overused, scab mites could also develop resistance to OP.

Lesley Stubbings of SCOPS, said maintaining two effective control methods was essential for the sheep sector's ability to control scab in the future.

“Understanding the basis of resistance in the MLs, together with the potential for early detection, will allow the industry to develop strategies to manage and slow resistance,” she said.

The project will use new tools, including samples of Psoroptes ovis mites that are either resistant or susceptible to ML treatment and a detailed map of their genes.

The project team will study these samples to understand how ML resistance has developed and then track how this resistance has spread across the UK.

Project partner Jack Hearn, of SRUC, said: “Translating basic research on the understanding of drug resistance in parasites to improve control strategies has undergone huge progress in recent years.

“We can now target parasites of veterinary importance like the mites that cause sheep scab with a variety of research methods.

“This will lead to much swifter recommendations for improved scab management than previously possible to the benefit of animal welfare and farmers.”